GFAP and prion disease: Notably, this calpain activation would not only produce GFAP cleavage products but may also downregulate PrPC, thereby removing the essential substrate for prion conversion and slowing the disease, a phenomenon proposed to underlie the extraordinary long incubation periods observed in prion diseases [56].